Biomedical Engineering Reference
In-Depth Information
429. Monteiro-Riviere, N. A.; Nemanich, R. A.; Inman, A. O.; Wang, Y. Y.; Riviere, J. E. Multi-
Walled Carbon Nanotube Interactions with Human Epidermal Keratinocytes.
Toxicol. Lett.
2005,
155,
377-384.
430. Arianna, F.; Alfred, N.
Reconfiguring Responsibility: Lessons for Nanoethics
. (Part 2 of the
Report on Deepening Debate on Nanotechnology); , 2009.
431. Faunce, T. A. Toxicological and Public Good Considerations for the Regulation of Nanomate-
rial-containing Medical Products.
Expert Opin. Drug Safety
2008,
7,
103-106.
432. Faunce, T. A. Policy Challenges of Nanomedicine for Australia's PBS.
Aust. Health Rev.
2009,
33,
258-267.
433. Faunce, T. A.; Nasu, H.; Murray, K.; Bowman, D. Sunscreen Safety: The Precautionary Prin-
ciple, The Australian Therapeutic Goods Administration and Nanoparticles in Sunscreens.
Nanoethics
2008,
2,
231-240.
434. Vines, T.; Faunce, T. A. Assessing the Safety and Cost-Effectiveness of Early Nanodrugs.
J. Law Med.
2007,
16,
822-845.
435. FDA
FDA and Nanotechnology Products: Frequently Asked Questions
. , 2007.
436. USFDA
FDA Issues Draft Guidance on Nanotechnology Documents Address use of Nano-
technology by Food and Cosmetics Industries
. 2012 Available from:
h
ttp://www.fda.gov/Cos-
437. USFDA
Cosmetics: Draft Guidance for Industry: Safety of Nanomaterials in Cosmetic
Products
. 2012 Available from:
h
ttp://www.fda.gov/Cosmetics/GuidanceComplianceRegula-
438. USFDA
Draft Guidance for Industry: Assessing the Effects of Significant Manufacturing Pro-
cess Changes, Including Emerging Technologies, on the Safety and Regulatory Status of Food
Ingredients and Food Contact Substances, Including Food Ingredients that are Color Addi-
tives
. 2012.
439. Commission, E.
Commission Recommendation on A Code of Conduct for Responsible Nano-
sciencesandNanotechnologiesResearch&CouncilConclusionsonResponsibleNanosciencesand
Nanotechnologies Research
. 2008 Available from:
h
ttp://ec.europa.eu/research/research-eu
.
440. Kehoe, S.; Zhang, X. F.; Boyd, D. FDA Approved Guidance Conduits and Wraps for Periph-
eral Nerve Injury: A Review of Materials and Efficacy.
Injury
2012,
43,
553-572.
441. Huang, Z.; Chen, H.; Chen, Z. K.; Roco, M. C. International Nanotechnology Development in
2003: Country, Institution, and Technology Field Analysis Based on USPTO Patent Database.
J. Nanopart. Res.
2004,
6,
325-354.
442. Igami, M.; Okazaki, T.
Capturing Nanotechnology's Current State Of Development Via Anal-
ysis Of Patents
. , 2007, DSTI/DOC. pages.
443. Koosha, A.; Ahmadi, M.; Nazifi, A.; Mousazadeh, R. Intellectual Property Rights of Nano-
Biotechnology in Trade Related Aspects of Intellectual Property Agreement (TRIPS).
Indian
J. Sci. Tech.
2012,
5,
2436-2442.
444. USPTO
Class 977 Nanotechnology Cross-Reference Art Collection
. 2012, June 24, 2012]. Avail-
445. Sargent, J. F. J.
The National Nanotechnology Initiative: Overview, Reauthorization, and
Appropriations Issues
. 2012, [cited 7-5700 RL34401].
446. Sizing Nanotechnology's Value Chain.
Lux
. 2004.
447. Heath, J. R.; Davis, M. E. Nanotechnology and cancer.
Annu Med Rev
.
2008
, 59, 251-265.
